Documents > FDA approval


ERRATA TO FDA BRIEFING DOCUMENT The following items

FDADocs 5/9/2008 | 0 (0) | 22 | 0 | 0 | English

ERRATA TO FDA BRIEFING DOCUMENT 1. The following items in the briefing document need to be corrected. Deletions are indicated by strikethrough and corrections are in italics. • • Page 7, last sentence, paragraph 3: PBSA replaced by S. aureus bacteremia. Page 11, last sentence: It is noteworthy that only 44% of all study patients completed treatme ...  more>>

FDA Amended Complaint for Injunction Selected Enforcement Actions onUnapproved Drugs

FDADocs 5/9/2008 | 0 (0) | 31 | 0 | 0 | English

Case 8:03-cv-01663-RAL-MSS Document 64 Filed 09/14/2004 Page 1 of 13 UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION UNITED STATES OF AMERICA, Plaintiff, v. PHARMAKON LABORATORY, INC., a Corporation; and ABELARDO L. ACEBO and EDWARD R. JACKSON, individuals, Defendants. _________________________________/ CASE NO. 8:03-cv-2 ...  more>>

Guidance for Industry on FDA Review of Vaccine Labeling

larryp 11/4/2008 | 0 (0) | 1 | 0 | 0 | English

FDA s Yearly Project Plan Its Principal Virtue Being an Obviation of Vagueness

FDADocs 5/8/2008 | 0 (0) | 12 | 0 | 0 | English

History Corner History Corner With permission from FDLI www.fdli.org FDA’s Yearly Project Plan: “Its Principal Virtue Being an Obviation of Vagueness” he Food and Drug Administration’s (FDA’s) Centennial also is the centennial of the “invention” of the federal food and drug inspector. The Bureau of Chemistry employed scientists from its inception ...  more>>

FDA dated April FDA CFSAN OPA Agency Response Letter to Archer Daniels Midland Company on plant sterols and plant sterol esters

FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English

FDA/CFSAN/OPA: Agency Response Letter : GRAS Notice No. GRN 000061 Page 1 of 3 4111 U. S. Food and Drug Administration Center for Food Safety & Applied Nutrition Office of I'remarket Approval Agency Response Letter GRAS Notice No. GRN 000061 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Washington, DC ...  more>>

FDA Executive Summary Prepared for the November Dental

FDADocs 5/9/2008 | 0 (0) | 39 | 0 | 0 | English

FDA Executive Summary Prepared for the November 9, 2006 Dental Products Panel Company: Device: Document No.: Date: Medtronic Sofamor Danek InFuse® Bone Graft P050053 October 4, 2006 InFuse® Bone Graft is a combination product consisting of a device and a biologic drug. FDA has determined that InFuse® will be reviewed as a PMA device/drug with cons ...  more>>

FDA CFSAN OPA Agency Response Letter to Proctor and Gamble on phytosterol esters

FDADocs 5/9/2008 | 0 (0) | 36 | 0 | 0 | English

FDA/CFSAN/OPA : Agency Response Letter : GRAS Notice No. GRN 000053 Page l of 3 4 0 U. S. Food and Drug Administration Center for Food Safety & Applied Nutrition Office of Premarket Approval Agency Response Letter GRAS Notice No. GRN 000053 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Washington, DC ...  more>>

Guidance for Industry and FDA Staff Guidance Document

GovernmentDocs 5/4/2008 | 0 (0) | 48 | 0 | 0 | English

Guidance for Industry and FDA Staff Guidance Document for Vascular Prostheses 510(k) Submissions Document issued on: November 1, 2000 This document supercedes Guidance Document for Vascular Prostheses 510(k) Submissions; Final, 11/26/1999 U.S. Department Of Health and Human Services Food and Drug Administration Center for Devices and Radiologica ...  more>>

DIA FDA point counterpoint KES

FDADocs 5/9/2008 | 0 (0) | 13 | 0 | 0 | English

Immunogenicity and Product Quality Attributes Point Immunogenicity of protein products cannot be predicted by biochemical/analytical techniques alone. – Comparative, side-by-side testing is needed – Up-to-date methods should be used Counterpoint The more like the innovator, the less immunogenicity testing is needed pre-marketing Factors which can ...  more>>

Draft Guidance for Industry and FDA Staff Whole

FDADocs 5/9/2008 | 0 (0) | 34 | 0 | 0 | English

Draft Guidance for Industry and FDA Staff: Whole Grains Label ~'taternents Docket No. 2006D-0066 References for Draft Guidance Tab I- 1 . U.S . Department of IJealtlh and Human Services and U .S . Department of Agriculture, "Dietary Guidelines for Americans, 2005q'° _I aAVW .b ea lt,hierus .-c>v/c~Yt,tar i.deli ncs, 2005 . Tab J - 2 . 1-loseney, R. ...  more>>

FDA Executive Summary Version Prepared for the March

FDADocs 5/9/2008 | 0 (0) | 35 | 0 | 0 | English

FDA Executive Summary (Version 2) Prepared for the March 27, 2006, meeting of the Obstetrics & Gynecology Devices Panel P050011 Innovata plc ® Adept Adhesion Reduction Solution (4% Icodextrin Solution) 1.) INDICATIONS FOR USE Adept Adhesion Reduction Solution (4% Icodextrin Solution) (Adept®) is intended for use as an adjunct to good surgical techn ...  more>>

Cover Letter from FDA

FDADocs 5/9/2008 | 0 (0) | 28 | 0 | 0 | English

" S SERwICP~~U~ . . . . . . . . .. . . . . . . , _ . .. . . . . . .. . . . . . . . . . . . .. . . . . . . . . o "`"e~a , ( ti+ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockvilie MD 20857 : Bruce S. Manheim, Jr. Ropes & Gray LLP One Metro Center Suite 900; 700 126' S ...  more>>


   
  results / page   15/25/50 Page: 30 of 34 << prev 1...2728293031323334 next >>